Etretinate (Tigason®) and Betamethasone Valerate (Celeston Valerate®) in the Treatment of Psoriasis

Publisher Website
Google Scholar
Abstract
A randomized trial with 146 psoriatic patients studied the relative merits of (1) oral etretinate (daily dose approximately 1 mg/kg body weight); (2) 0,1% betamethasone valerate cream twice daily, and (3) a combination of treatments 1 and 2. The combined treatment was the best and betamethasone valerate alone was on the whole inferior.

This publication has 2 references indexed in Scilit: